Abstract
Lipophilic masked aryloxyaminoacylphosphoramidate derivatives of 2',3'-dideoxynucleoside (ddN) analogues with potent anti-HIV activity (i.e., stavudine [d4T], azidothymidine [AZT], dideoxycytidine [ddC], 3'thio-2',3'-dideoxy cytidine [3TC], dideoxyadenosine [ddA], and 2',3'-didehydro-2',3'-dideoxyadenosine [d4A]) activity were evaluated for their activity against visna virus (VV) in sheep choroid plexus (SCP) cells. The activity of several prodrug derivatives against VV proved markedly superior to that of the corresponding free ddN analogues. In particular, the d4A and ddA prodrug derivatives were exquisitely inhibitory in this model system (50% effective concentration [EC50], < or = 0.003 microM), and their anti-VV potency exceeded by at least 200-fold the antiviral potency of the corresponding free nucleosides. Marked differences were noted in the anti-VV potencies of several of the test compounds depending on the nature of the amino acid linked to the 5'-phosphate moiety, the nature of the nucleoside, or both. In view of the stability of the prodrugs in lamb serum, the VV infection model in lambs may be considered highly useful for investigating the in vivo antiretroviral efficacy of these type of drugs, particularly the d4T...Continue Reading
References
Jul 1, 1991·Antiviral Research·L NaesensE De Clercq
Jan 1, 1991·AIDS·J P Moore, P L Nara
Jan 1, 1991·AIDS·J BalzariniE De Clercq
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·H EgberinkM Koolen
Aug 1, 1985·Cell·P SonigoS Wain-Hobson
Nov 1, 1989·Antimicrobial Agents and Chemotherapy·J D GangemiH K Hochkeppel
Jan 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J BalzariniE De Clercq
Jan 11, 1985·Science·M A GondaR V Gilden
Apr 1, 1986·Journal of Virology·H E GendelmanG Pezeshkpour
Dec 1, 1993·Antimicrobial Agents and Chemotherapy·H ThormarE De Clercq
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·H ThormarE De Clercq
Apr 15, 1994·Pharmacy World & Science : PWS·J Balzarini
Feb 1, 1994·The Journal of Infectious Diseases·C C TsaiN Bischofberger
May 10, 1996·Journal of Medicinal Chemistry·G ValetteJ L Imbach
Apr 12, 1996·Journal of Medicinal Chemistry·C McGuiganJ Balzarini
Jul 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·J BalzariniC McGuigan
Aug 14, 1996·Biochemical and Biophysical Research Communications·J BalzariniC McGuigan
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·K K Van RompayN C Pedersen
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·J Ross
Jun 30, 1997·FEBS Letters·J BalzariniC McGuigan
Citations
Feb 13, 2001·Biochemical Pharmacology·D B LackeyM Pegram
Jan 1, 2016·BioImpacts : BI·Jaleh BararYadollah Omidi
Mar 20, 2002·Antiviral Chemistry & Chemotherapy·J BalzariniC Meier
Nov 4, 2000·Medicinal Research Reviews·C R WagnerE J McIntee